
Injection · 10 mg/mL (tirzepatide)

A dual GIP/GLP-1 agonist — the most effective weight-loss injection studied to date. Reduces appetite, improves insulin sensitivity, and supports meaningful, sustained loss. Our formulation adds B12 and glycine to reduce side effects and preserve muscle.


Answer a few health questions — a licensed provider reviews online. No waiting rooms.

Once approved, your medication ships discreetly to your door.


Physician-guided support and check-ins keep results on track.

Inject 50 units (5 mg) subcutaneously once a week for 12 weeks; titrate at clinician discretion; lowest effective dose; do not escalate with active side effects
Tirzepatide caused thyroid C-cell tumors in rats. Whether that happens in people is not known.
Tell your care team straight away if you feel a lump or swelling in your neck, your voice goes hoarse or swallowing becomes hard, you get severe stomach pain that will not stop, you cannot keep up with vomiting or diarrhea, you get pain in your upper right belly or your eyes turn yellow, or you get a rash with swelling of the face or lips or trouble breathing.
Common side effects
Rare but serious
Do not take this if you or a family member has had medullary thyroid carcinoma, you have Multiple Endocrine Neoplasia syndrome type 2, or you have reacted badly to tirzepatide before.
This is not a complete list of side effects. Message your care team about any symptom that worries you. What we dispense is a compounded preparation made by a licensed US pharmacy. Compounded medications are not approved by the FDA for safety, efficacy or quality.
Tirzepatide acts on two gut hormone receptors, GIP and GLP-1, rather than one. In trials it produced greater average weight loss, though individual response varies and side effects are broadly similar.
Once weekly, as a small subcutaneous injection at home. This formulation also includes glycine and B12.
Steadily, over months. The early weeks are about stepping the dose up and letting your body adjust rather than chasing the scale.
Nausea, constipation, diarrhoea and reflux are the most common, and are usually worst in the days after a dose increase. Eating smaller portions more slowly helps. Tell your clinician about anything severe or persistent.
Appetite generally returns and weight regain is common without other changes in place. This is why the habits you build during treatment matter as much as the medication.
It is not appropriate if you have a personal or family history of medullary thyroid carcinoma or MEN 2, and it is not for use in pregnancy. Your intake covers the full list of contraindications.

Globally recognized aging biologist and former CEO of the Buck Institute for Research on Aging, renowned for pioneering research on sirtuins, mTOR, and healthy aging.

World-leading biogerontologist and Founding Director of the Healthy Aging & Longevity Research Institute, celebrated for uncovering the biological mechanisms of aging.

Board-certified Family Nurse Practitioner with 15+ years of clinical experience, specializing in preventative wellness and biomarker-driven personalized care.